Market regulation · 30/08/2001
FDA Stays Enforcement of Lidoderm Patch Packaging Requirements
The US FDA has issued a notice announcing a stay of enforcement for special packaging requirements of the orphan drug Lidoderm, allowing the manufacturer to continue using its current packaging until further notice.
Original source language: Federal Register — Consumer Product Safety CommissionOpen original release →